Die antimykotische Chemotherapie opportunistischer Pilzinfektionen

[1]  B. Dupont.  Itraconazole therapy in aspergillosis: study in 49 patients. , 1990, Journal of the American Academy of Dermatology.

[2]  A. Tortorano,et al.  European experience with itraconazole in systemic mycoses. , 1990, Journal of the American Academy of Dermatology.

[3]  L. Chan,et al.  Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. , 1990, Annals of internal medicine.

[4]  A. Polak,et al.  Combination therapy in systemic mycosis. , 1990, Journal of chemotherapy.

[5]  T. Shimozato,et al.  Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice , 1990, Infection and immunity.

[6]  A. Cassone,et al.  Candidal endocarditis and treatment with fluconazole and granulocyte-macrophage colony-stimulating factor. , 1990, Annals of Internal Medicine.

[7]  P. Robinson,et al.  Fluconazole for life-threatening fungal infections in patients who cannot be treated with conventional antifungal agents. , 1990, Reviews of infectious diseases.

[8]  F. Meunier,et al.  Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole. , 1990, Reviews of infectious diseases.

[9]  B. Dupont,et al.  Overview: treatment of cryptococcal meningitis. , 1990, Reviews of infectious diseases.

[10]  R. Hay.  Overview of studies of fluconazole in oropharyngeal candidiasis. , 1990, Reviews of infectious diseases.

[11]  D. Armstrong,et al.  Problems in management of opportunistic fungal diseases. , 1989, Reviews of infectious diseases.

[12]  F. Meunier.  New methods for delivery of antifungal agents. , 1989, Reviews of infectious diseases.

[13]  P. Narciso,et al.  Fluconazole treatment of cryptococcosis in patients with acquired immunodeficiency syndrome. , 1989, The American journal of medicine.

[14]  K. Holmberg,et al.  Diagnosis and Therapy of Systemic Fungal Infections , 1989 .

[15]  R. M. Tucker,et al.  Treatment of invasive aspergillosis with itraconazole. , 1989, The American journal of medicine.

[16]  T. Chan,et al.  Fungal peritonitis complicating peritoneal dialysis: report of 27 cases and review of treatment. , 1989, The Quarterly journal of medicine.

[17]  A. Sugar,et al.  Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. , 1988, The American journal of medicine.

[18]  K. Squires,et al.  Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. , 1988, The American journal of medicine.

[19]  P. Pizzo,et al.  Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia. , 1988, The Journal of infectious diseases.

[20]  J. Klastersky,et al.  Recent developments in prophylaxis and therapy of invasive fungal infections in granulocytopenic cancer patients. , 1988, European journal of cancer & clinical oncology.

[21]  A. Polak.  Combination therapy with antifungal drugs. , 1988, Mykosen. Supplement.

[22]  E. Fishman,et al.  Favorable outcome of invasive aspergillosis in patients with acute leukemia. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  H. Nomura,et al.  Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice , 1987, Infection and immunity.

[24]  R. Diasio,et al.  Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. , 1987, The New England journal of medicine.

[25]  G. Cauwenbergh,et al.  Experience with Itraconazole in Deep Mycoses in Northern Italy. Erfahrungen mit Itraconazol bei tieflokalisierten Mykosen in Norditalien , 1987, Mykosen.

[26]  A. Polak.  Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. , 1987, Chemotherapy.

[27]  D. Borelli.  A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis. , 1987, Reviews of infectious diseases.

[28]  B. Dupont,et al.  Cutaneous, ocular, and osteoarticular candidiasis in heroin addicts: new clinical and therapeutic aspects in 38 patients. , 1985, The Journal of infectious diseases.

[29]  A. Schaffner,et al.  The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis. , 1985, The Journal of infectious diseases.

[30]  A. Fanaroff,et al.  Disseminated fungal infections in very low-birth-weight infants: therapeutic toxicity. , 1984, Pediatrics.

[31]  A. Polak,et al.  Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice. , 1982, Chemotherapy.

[32]  D. Alling,et al.  A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. , 1979, The New England journal of medicine.